GLP-1 hair loss is a growing concern among the 20 million people in the US, UK, and EU taking medications like Ozempic and Mounjaro for weight loss and type 2 diabetes. As these drugs surge in popularity, reports of hair shedding have caught researchers' attention. In one survey, 20% of respondents experienced hair loss, though the lack of randomized controlled trial data makes it hard to know exactly how common it is. While often temporary and reversible, GLP-1-related hair loss is significant enough that some patients hesitate to start or continue these otherwise beneficial drugs.
What Types of Hair Loss Are Linked to GLP-1 Drugs?
Most people on GLP-1 drugs don't experience hair loss. However, those who do often notice it within the first year, peaking around the 12-month mark. According to Lynn Petukhova, a geneticist at New York University who studies hair loss disorders, they usually experience one of two types. The most common is telogen effluvium, a stress-related condition where a stressor pushes an unusually large share of hair follicles into their resting phase. During this stage, affected hair ceases to grow and eventually falls out, typically two to three months after the triggering event. The second type is androgenetic alopecia, or pattern baldness, which is more permanent and influenced by genetics and hormones. However, GLP-1 drugs are more commonly associated with telogen effluvium.
Why Do GLP-1 Drugs Cause Hair Loss?
The exact mechanism isn't fully understood, but several factors likely contribute. Rapid weight loss itself is a known trigger for telogen effluvium, as it stresses the body and diverts energy away from hair growth. Additionally, GLP-1 drugs can cause nausea, vomiting, and reduced appetite, leading to nutritional deficiencies in protein, iron, zinc, and vitamins D and B12—all essential for healthy hair. The drugs may also affect hormone levels, though this is less clear. It's important to note that hair loss is not listed as a common side effect in clinical trials, but real-world reports have brought it to light.
How Common Is Hair Loss with GLP-1 Medications?
Data on the prevalence of GLP-1 hair loss is limited. The survey mentioned earlier found that 20% of respondents experienced shedding, but surveys can be biased. Clinical trials for semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) reported hair loss in 3-5% of participants, though these trials weren't designed to specifically track hair loss. The true incidence may lie somewhere in between. A comparison of reported rates is shown below.
| Medication | Reported Hair Loss Rate |
|---|---|
| Semaglutide (Ozempic/Wegovy) | ~3-5% in trials |
| Tirzepatide (Mounjaro/Zepbound) | ~3-5% in trials |
| Survey respondents | 20% |
Key Takeaways
- GLP-1 hair loss is often temporary and reversible, typically resolving within 6-12 months after the trigger is removed.
- Telogen effluvium is the most common type, caused by stress, rapid weight loss, or nutritional deficiencies.
- Not everyone experiences hair loss; reported rates range from 3-5% in clinical trials to 20% in surveys.
- Managing nutrition and stress may help prevent or reduce hair shedding while on GLP-1 drugs.
- Consult your healthcare provider if you notice significant hair loss; they can check for deficiencies and adjust your treatment.
What Can You Do About GLP-1 Hair Loss?
If you're experiencing hair loss while taking a GLP-1 drug, don't panic. First, talk to your doctor to rule out other causes like thyroid issues or iron deficiency. They may recommend blood tests to check your levels. Ensure you're eating a balanced diet with adequate protein, iron, and vitamins. Some patients find that slowing the rate of weight loss helps reduce shedding. If hair loss persists, treatments like minoxidil (Rogaine) or low-level laser therapy may be options. In most cases, hair regrows once the body adjusts or the medication is stopped, but always consult your healthcare provider before making changes.
FAQ
Is hair loss a common side effect of Ozempic?
Hair loss is not listed as a common side effect in clinical trials, but real-world reports suggest it can occur. In trials, about 3-5% of participants reported hair loss, while surveys indicate up to 20% may experience it. It's often temporary.
Does Mounjaro cause more hair loss than Ozempic?
Both semaglutide (Ozempic) and tirzepatide (Mounjaro) have been associated with hair loss at similar rates in clinical trials (around 3-5%). There is no strong evidence that one causes more hair loss than the other.
Is GLP-1 hair loss permanent?
In most cases, GLP-1 hair loss is temporary and reversible. Telogen effluvium resolves once the stressor is removed or the body adjusts. However, if you have underlying androgenetic alopecia, hair loss may be permanent without treatment.
Best Products We’ve Tested and Rated

Our testing team has hands-on reviews of walking shoes supination, sumo deadlift shoes, work boots plantar fasciitis, cushioned running shoes, and womens running shoes it band syndrome. Every option below was compared across price, build quality, and real-world performance, with honest pros and cons. We update these guides regularly as new models arrive, so the recommendations stay current.
Our testing team has hands-on reviews of trampoline ski training, leg press hack squat combo, 4d massage chair, stall bars, and speed bag platform home. Every option below was compared across price, build quality, and real-world performance, with honest pros and cons. We update these guides regularly as new models arrive, so the recommendations stay current.